Benedict’s Law: UK Government Mandates Life-Saving Allergy Protections in Schools

In a landmark move for child safety, the Department for Education has announced that life-saving adrenaline auto-injectors (AAIs) must be stocked by all schools in England for the first time. The new statutory requirements, set to come into force in September 2026, replace previous non-statutory advice with a rigorous legal framework designed to prevent avoidable tragedies.

The plans—widely referred to as "Benedict’s Law"—are a response to tireless campaigning by the families of children who lost their lives to allergic reactions at school, including Helen and Peter Blythe, whose five-year-old son Benedict died in 2021.

The New Guidance

The government's new guidance shifts allergy management from "recommended" to compulsory. Schools must now adhere to three core requirements:

1. Mandatory Spare "Allergy Pens": Schools must stock "spare" adrenaline auto-injectors (such as EpiPens or Jext) for emergency use if a pupil’s own device fails or is unavailable.

2. Compulsory Staff Training: Every member of staff must receive allergy awareness training. This covers symptom recognition, emergency response protocols, and the practical use of adrenaline devices.

3. Individual Healthcare Plans (IHPs): Every school must maintain a comprehensive policy for medical conditions, with specific IHPs for individual pupils to ensure their unique allergy triggers and emergency needs are documented.

The Cost of Inaction: Learning and Lives

Beyond the critical goal of saving lives, the government highlighted the significant educational impact of poorly managed allergies:

• 500,000 Days of Learning: Absences due to allergy-related illnesses or medical appointments; and

• Inconsistency: Previous "voluntary" guidance led to a "postcode lottery" of safety, where some pupils were protected by robust policies while others were at risk.

Broader Medical Support: Epilepsy and Diabetes

The 2026 guidance also expands protections for children with other chronic health conditions, ensuring schools are equipped for modern medical management:

• Epilepsy: IHPs must now specifically detail seizure types and emergency protocols. The guidance has been broadened to include early years settings and colleges; and

• Diabetes: Schools are now required to support pupils using Continuous Glucose Monitors (CGMs) and insulin pumps, including the use of linked mobile phone apps, reflecting the rise in Type 1 and Type 2 diabetes among youth

Implementation and Next Steps

The government has launched an open consultation on the new guidance, allowing educators and families to provide feedback before the September 2026 deadline.

To assist with the transition, the government is issuing an "open call" to businesses to help support the costs of adrenaline devices, while organizations like The Allergy Team and The Natasha Allergy Research Foundation stand ready to provide standardized training resources for the 20,000+ educators across the country